Gsk Plc-spon Adr. share price logo

Gsk Plc-spon Adr. Share Price

NYSE: GSK

Large Cap

$51.83

-0.54

(-1.03%)

as on

Gsk Plc-spon Adr. Stock Performance

as on March 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $51.55
    $52.40
    downward going graph

    0.54%

    Downside

    1.10%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $32.38
    $61.70
    downward going graph

    37.53%

    Downside

    19.03%

    Upside

    downward going graph

Gsk Plc-spon Adr. share price movements today

Previous Close
$52.37
Open
$52.12
Volume
3.8M
Day's Low - High
$51.55 - $52.40
52 Week Low - High
$32.38 - $61.70

Gsk Plc-spon Adr. Historical Returns

1 Month Return
-12.9 %
3 Month Return
+ 6.64 %
1 Year Return
+ 32.11 %
3 Year Return
+ 47.9 %
5 Year Return
+ 13.22 %

Gsk Plc-spon Adr. Stock Fundamentals & Key Indicators

Check Gsk Plc-spon Adr. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$105.2B

EPS (TTM)

4.7713

Dividend Yield

3.45%

Quarterly Earnings Growth YOY

0.55%

PE Ratio (TTM)

14.12

Industry PE ratio

19.338333333333335

PEG Ratio

0.4986

EBITDA

11.3B

Revenue (TTM)

32.7B

Profit Margin

17.50%

Return On Equity TTM

43.31%

Gsk Plc-spon Adr. Stock Valuation

Track how Gsk Plc-spon Adr. P/E has moved over time to understand its valuation trends.

Gsk Plc-spon Adr. in the last 5 years

  • Overview

  • Trends

Lowest (8.73x)

September 30, 2025

Today (14.12x)

March 21, 2026

Industry (19.34x)

March 21, 2026

Highest (13.53x)

June 30, 2022

LowHigh

Today’s Price to Earnings Ratio: 14.12x

Gsk Plc-spon Adr. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Gsk Plc-spon Adr. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$105.2B13.22%14.1217.50%
BUY$292.9B273.09%28.8917.41%
BUY$821.2B392%39.9831.67%
BUY$572.6B47.07%21.5628.46%
BUY$364.6B98.29%87.026.91%

Stock Returns calculator for Gsk Plc-spon Adr. Stock including INR - Dollar returns

The Gsk Plc-spon Adr. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Gsk Plc-spon Adr. investment value today

Current value as on today

₹1,40,989

Returns

₹40,989

(+40.99%)

Returns from Gsk Plc-spon Adr. Stock

₹32,085 (+32.08%)

Dollar Returns*

₹8,904 (+8.9%)

Analyst Recommendation on Gsk Plc-spon Adr. Stock

Based on 33 analysts

BUY

60.61%

Buy

30.30%

Hold

9.09%

Sell

Based on 33 analysts, 60.61% of analysts recommend a 'BUY' rating for Gsk Plc-spon Adr.. Average target price of $57.48

Gsk Plc-spon Adr. Share Price Target

Get share price movements and forecasts by analysts on Gsk Plc-spon Adr..

What analysts predicted

9.83%UPSIDE

Target Price

$57.48

Current Price

$51.83

Analyzed by

33 Analysts

Target

$57.48

Gsk Plc-spon Adr. target price $57.48, a slight upside of 9.83% compared to current price of $51.83. According to 33 analysts rating.

Gsk Plc-spon Adr. Stock’s Investor Sentiment and Interest

Search interest for Gsk Plc-spon Adr. Stock has decreased by -34% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-34% versus previous 30 day period

Gsk Plc-spon Adr. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
10,111
10,193
9,358
10,020
10,581
10,262
9,698
7,986
8,547
8,618
Gross Profit
7,291
7,132
6,854
7,323
7,415
7,026
7,199
5,821
6,289
6,007
Operating Income
1,949
573
1,490
1,646
189
696
2,216
2,023
2,593
1,100
EBITDA
2,552
1,157
2,070
2,308
1,171
1,119
3,093
3,230
3,361
1,938
Interest Expense
182
275
166
174
156
144
162
184
167
185
Depreciation
579
623
549
639
951
412
823
1,159
738
-406
Income Before Tax
1,791
379
1,355
1,495
64
563
2,108
1,887
2,456
950
Income Tax Expense
257
-19
274
191
-1
62
336
241
312
223
Net Income
1,816
443
1,329
1,490
-76
523
2,095
1,443
2,013
636
Net Profit Margin
17.97%
4.35%
14.21%
14.88%
-0.72%
5.10%
21.61%
18.07%
23.55%
7.38%

Gsk Plc-spon Adr. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
34,795
40,461
39,032
44,193
32,713
32,855
35,696
38,395
39,667
31,951
Gross Profit
23,204
26,599
26,062
28,661
22,063
21,995
24,066
27,551
28,228
23,178
Operating Income
2,598
4,087
5,483
6,961
5,979
4,357
6,433
6,745
4,021
7,011
EBITDA
4,430
6,184
7,350
9,220
8,067
6,485
8,601
9,083
6,668
11,622
Interest Expense
736
734
743
912
892
784
855
775
657
685
Depreciation
-
1,922
1,856
2,334
2,351
2,524
2,298
1,527
2,551
2,314
Income Before Tax
1,939
3,525
4,800
6,221
5,170
3,599
5,628
6,064
3,477
7,238
Income Tax Expense
877
1,356
754
953
67
83
707
756
526
1,087
Net Income
1,137
2,053
4,588
6,081
7,722
5,833
18,206
6,238
3,255
5,590
Net Profit Margin
3.27%
5.08%
11.75%
13.76%
23.61%
17.76%
51.00%
16.25%
8.21%
17.50%

Gsk Plc-spon Adr. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
434
1,326
1,304
65
501
1,772
1,646
2,714
627
Operating Cash Flow
3,618
1,190
1,113
2,154
2,329
1,145
2,096
3,027
2,036
Investing Cash Flow
292
-254
770
-731
-1,119
-1,144
-625
-2,150
-2,362
Financing Cash Flow
-4,063
-1,253
-1,584
-1,240
-842
858
-2,372
-1,706
808
Change in Cash
-134
-218
291
149
375
848
-927
-494
97

Gsk Plc-spon Adr. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
2,169
4,046
5,268
6,388
5,096
4,921
6,125
2,951
5,590
Operating Cash Flow
6,918
8,421
8,020
8,441
7,952
7,403
7,890
6,554
7,142
Investing Cash Flow
-1,443
-1,553
-5,354
2,161
-1,777
-8,772
-2,404
-1,229
-5,722
Financing Cash Flow
-6,380
-6,389
-1,840
-10,132
-7,589
823
-6,068
-4,726
-1,593
Change in Cash
-1,005
487
744
431
-1,443
-394
-735
545
-206

Global Institutional Holdings in Gsk Plc-spon Adr.

Funds
Holdings
PRIMECAP Management Company
1.25%
Royal Bank of Canada
0.44%
JTC Employer Solutions Trustee Ltd
0.73%
Fisher Asset Management, LLC
1.61%
Goldman Sachs Group Inc
0.31%

Gsk Plc-spon Adr. News & Key Events

  • img

    Today's Timeline - 10 March

    Tue, 06:30 PM

    -

    FDA approves leucovorin as the first drug for cerebral folate deficiency, allowing generics to carry the new indication.

    Tue, 09:08 PM

    -

    GSK signs a license agreement with Alfasigma for linerixibat, receiving $300 million upfront and potential milestone payments.

Insights on Gsk Plc-spon Adr.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    GSK Plc's revenue has consistently increased over the last 4 quarters, growing from $7.51 billion to $8.61 billion. This represents an average quarterly increase of 4.4%.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, GSK stock has moved up by 27.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, ASTRAZENECA PLC has given 145.0% return, outperforming this stock by 112.9%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, ASTRAZENECA PLC has given 174.1% return, outperforming this stock by 126.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    GSK Plc has experienced a significant decline in its net profit over the last two quarters. The profit dropped from $2.01 billion to $636 million, reflecting an average decrease of 68.4% per quarter.

About Gsk Plc-spon Adr.

GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England.
OrganisationGsk Plc-spon Adr.
Headquarters79 New Oxford Street, London, United Kingdom, WC1A 1DG
IndustryHealth Technology
CEOMr. Luke Victor Miels
E-voting on sharesClick here to vote

Key Management of Gsk Plc-spon Adr.

Name

Title

Ms. Diana Conrad

Chief People Officer

Ms. Julie Belita Brown A.C.A.

CFO & Executive Director

Dr. Jesse L. Goodman M.D., M.P.H.

Scientific & Medical Expert

Mr. Luke Victor Miels

CEO & Director

Ms. Shobie Ramakrishnan

Chief Digital & Technology Officer

Mr. Tony Wood

Chief Scientific Officer and Head of R&D

Mr. Constantin Fest

Senior VP & Head of Investor Relations

Mr. James Ford

Senior VP and Group General Counsel of Legal & Compliance

Mr. David Simon Redfern BSc (Hons), CA

President of Corporate Development

Ms. Emma Natasha Walmsley

Executive Officer

FAQs

What is Gsk Plc-spon Adr. share price today?

Gsk Plc-spon Adr. share price today is $51.83 as on at the close of the market. Gsk Plc-spon Adr. share today touched a day high of $52.4 and a low of $51.55.

What is the 52 week high and 52 week low for Gsk Plc-spon Adr. share?

Gsk Plc-spon Adr. share touched a 52 week high of $61.7 on and a 52 week low of $32.38 on . Gsk Plc-spon Adr. stock price today i.e. is closed at $51.83,which is 15.99% down from its 52 week high and 60.07% up from its 52 week low.

What is Gsk Plc-spon Adr.'s market capitalisation today?

Gsk Plc-spon Adr. market capitalisation is $0.11T as on .

How to invest in Gsk Plc-spon Adr. Stock (GSK) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Gsk Plc-spon Adr. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Gsk Plc-spon Adr. Shares that will get you 0.0289 shares as per Gsk Plc-spon Adr. share price of $51.83 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Gsk Plc-spon Adr. Stock (GSK) from India?

Indian investors can start investing in Gsk Plc-spon Adr. (GSK) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Gsk Plc-spon Adr. stock (as per the Rupee-Dollar exchange rate as on ). Based on Gsk Plc-spon Adr. share’s latest price of $51.83 as on March 21, 2026 at 1:29 am IST, you will get 0.1929 shares of Gsk Plc-spon Adr.. Learn more about fractional shares .

What are the returns that Gsk Plc-spon Adr. has given to Indian investors in the last 5 years?

Gsk Plc-spon Adr. stock has given 13.22% share price returns and 28.67% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?